Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481247
Status:
COMPLETED
Last Update Posted:
2017-02-15
First Post:
2007-05-30
Brief Title:
A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myeloid Leukemia Chronic |
Keywords:
| Name | View |
|---|---|
| Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia | View |